Quick Answer
ESCALON MEDICAL CORP reported Operating Income Loss of $133.2 thousand for the year ending 2025.
- ESCALON MEDICAL CORP showed an increase of +227.5% in Operating Income Loss from 2024 to 2025.
- This data is from ESCALON MEDICAL CORP's annual report (Form 10-K), filed with the SEC on September 29, 2025.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2010: -$849.2 thousand | Q4 2010: -$799.5 thousand | Q1 2011: -$1.69 million | Q3 2011: -$419.3 thousand | Q4 2011: -$21.2 thousand | Q1 2012: -$263.8 thousand | Q3 2012: -$596.6 thousand | Q4 2012: $109.6 thousand | Q1 2013: -$294.9 thousand | Q3 2013: $37.7 thousand | Q4 2013: -$89.3 thousand | Q1 2014: $112.3 thousand | Q3 2014: -$440.2 thousand | Q4 2014: -$76.8 thousand | Q1 2015: $7.4 thousand | Q3 2015: -$293.2 thousand | Q4 2015: -$265.1 thousand | Q1 2016: -$78.2 thousand | Q3 2016: -$385.3 thousand | Q4 2016: -$42.5 thousand | Q1 2017: -$73.9 thousand | Q3 2017: -$27.3 thousand | Q4 2017: $245.1 thousand | Q1 2018: -$92.3 thousand | Q3 2018: -$43.4 thousand | Q4 2018: -$226.5 thousand | Q1 2019: $22.2 thousand | Q3 2019: -$133.7 thousand | Q4 2019: -$673.0 thousand | Q1 2020: -$128.3 thousand | Q3 2020: -$191.6 thousand | Q4 2020: $103.8 thousand | Q1 2021: -$132.2 thousand | Q3 2021: -$184.5 thousand | Q4 2021: -$49.1 thousand | Q1 2022: -$291.9 thousand | Q3 2022: -$315.9 thousand | Q4 2022: $3.00 | Q1 2023: $589.6 thousand | Q3 2023: -$15.6 thousand | Q4 2023: -$70.5 thousand | Q1 2024: -$156.6 thousand | Q3 2024: -$27.0 thousand | Q4 2024: $255.9 thousand | Q1 2025: $276.0 thousand | Q3 2025: -$202.8 thousand | Q4 2025: $98.7 thousand.
- Over the full 15 years of available data (2011 to 2025), ESCALON MEDICAL CORP's Operating Income Loss has grown by 102.7%.
- Historical annual values: Fiscal year 2025: $133.2 thousand | Fiscal year 2024: -$104.5 thousand | Fiscal year 2023: $478.5 thousand | Fiscal year 2022: -$470.1 thousand | Fiscal year 2021: -$33.7 thousand | Fiscal year 2020: -$1.40 million | Fiscal year 2019: -$253.0 thousand | Fiscal year 2018: $204.7 thousand | Fiscal year 2017: -$626.9 thousand | Fiscal year 2016: -$1.14 million | Fiscal year 2015: -$1.05 million | Fiscal year 2014: -$357.5 thousand | Fiscal year 2013: -$1.23 million | Fiscal year 2012: -$1.32 million | Fiscal year 2011: -$4.86 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: